Newly-founded Scottish medtech firm EnMovi has been granted £2.5 million by Scottish Enterprise to further its research and development.
The firm, which was incorporated in October 2019 and is a subsidiary of US-based OrthoSensor and McLaren Applied, will utilise the grant to fund its research into new wearable technology, data analytics and an app.
EnMovi’s app is expected to be geared towards improving patient recovery in Scotland, providing rehabilitation guides, home exercise plans and contact with healthcare professionals.
Furthermore, EnMovi’s new research and development facility at the University of Strathclyde is forecast to create 19 jobs.
EnMovi CEO Roman Bensen said: “The support provided by Scottish Enterprise and our long-standing collaboration with the prestigious University of Strathclyde will enable us to continue the development of our innovative data analytics and wearable platform to improve patient outcomes globally.”
Trade, investment and innovation minister Ivan McKee said: “This funding will support EnMovi to capture data and develop wearable technology. This will allow for less invasive surgery and faster recovery times for patients.”
“This project, which will see a new research and development centre established at the University of Strathclyde’s Inovo building, also brings exciting employment opportunities and will help establish Scotland at the forefront of research into this cutting-edge new technology.”